Brief: Preciseonco Research Consortium Awarded EUR 14.9 Million Grant In Precision Cancer Treatment
Feb 3 (Reuters) - Koninklijke Philips NV PHG.AS: PRECISEONCO RESEARCH CONSORTIUM AWARDED EUR 14.9 MILLION IHI GRANT TO DRIVE BREAKTHROUGHS IN PRECISION CANCER TREATMENT CO-FUNDED BY EU'S INNOVATIVE HEALTH INITIATIVE (IHI) EUR 14.9 MILLION PUBLIC FUNDING WILL BE COMPLEMENTED BY EUR 9 MILLION IN IN-KIND CONTRIBUTIONS AND ADDITIONAL RESOURCES FROM INDUSTRY PARTNERS Source text: [ID:] Further company coverage: PHG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Koninklijke Philips
See all newsEurope Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
Philips rises after beating adjusted EBITA estimates
Koninklijke Philips N.V. reports results for the quarter ended September 30 - Earnings Summary
Philips reaches DOJ agreement over device recall, books €288 million provision in Q3 (updated)